Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial
- 11 May 2002
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 359 (9318), 1648-1654
- https://doi.org/10.1016/s0140-6736(02)08597-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the communityThorax, 2001
- A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin–clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcomeInternational Journal of Antimicrobial Agents, 1998
- Assessing the minimal important difference in symptoms: A comparison of two techniquesJournal of Clinical Epidemiology, 1996
- Interpretation of rhinoconjunctivitis quality of life questionnaire dataJournal of Allergy and Clinical Immunology, 1996
- Acute bronchitis: course of symptoms and restrictions in patients' daily activitiesScandinavian Journal of Primary Health Care, 1995
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994
- Symptomatic Effect of Inhaled Fenoterol in Acute Bronchitis: A Placebo-Controlled Double-Blind StudyFamily Practice, 1991
- Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitisClinical and Experimental Allergy, 1991
- A measure of quality of life for clinical trials in chronic lung disease.Thorax, 1987
- Randomised controlled trial of antibiotics in patients with cough and purulent sputum.BMJ, 1976